Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400080234Phase 4Recruiting
Phase 4, randomised trial in respiratory failure comparing Remimazolam arm with Propofol arm (2 arms). Primary endpoints: Sedation Achievement Rate and Sedation Achievement Time. Started Jan 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400080234.